The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Gabitril 5 mg, film-coated tablet

Teva Pharma B.V.PA0749/199/001

Main Information

Trade NameGabitril 5 mg, film-coated tablet
Active SubstancesTiagabine anhydrous
Dosage FormFilm-coated tablet
Licence HolderTeva Pharma B.V.
Licence NumberPA0749/199/001

Group Information

ATC CodeN03AG Fatty acid derivatives
N03AG06 tiagabine


License statusAuthorised
Licence Issued07/03/1997
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back